Sermorelin dose range

The amounts people commonly use, from the low end to the high end, with syringe units, schedule and half-life. The 8 published studies are one click away.

Small human studies Growth hormone axis Also called GRF 1-29

Common use ranges

From published clinic and pharmacy protocols. No drug label exists. No current adult label. The old Geref label was for children. Adult clinic protocols use 200 to 500 mcg at bedtime and adjust by IGF-1 blood tests.

Half-life
about 6 to 7 minutes in the vein
How it is taken
subcutaneous injection
How long people use it
3 to 6 months or longer. After 6 months some use 5 days on, 2 days off.
Mixing used for the units
9 mg vial + 2 mL water. 1 unit on a U-100 insulin syringe = 45 mcg.
Total amount per day, by tier
Starting200 mcg / dayTypical300 mcg / dayHigher500 mcg / day
TierEach doseSyringe units9 mg vial + 2 mL waterHow oftenScheduleVial lastsat this tier
Starting [1]200 mcg4.4 units 0.04 mLonce a day200 to 300 mcg at bedtime on an empty stomach, weeks 1 to 86+ weeks
Typical [2]300 mcg6.7 units 0.07 mLonce a day300 to 400 mcg at bedtime, set by IGF-1 blood testsabout 4 weeks
Higher [3]500 mcg11.1 units 0.11 mLonce a dayUp to 500 mcg at bedtime18 days

Good to know

  • The old Geref label dose for children was 30 mcg per kg a day. Adult protocols do not use that formula.

Sources for these amounts

  1. Starting: Pure Peptide Clinic, sermorelin dosage
  2. Typical: Pure Peptide Clinic, sermorelin dosage
  3. Higher: Pure Peptide Clinic, sermorelin dosage

How long people use it: Pure Peptide Clinic, sermorelin dosage

Half-life: Geref 50 (sermorelin) product information, Ireland HPRA

This page shows what labels, clinics and users report, and what studies gave. It is not medical advice and not a recommendation for anyone. Many of these compounds are not approved for human use. Check your own medicines and lab work with a licensed clinician before using anything.

See the science: 8 published studies

Amounts given to people in studies

Lowest0.25 mcg/kg IV (test dose)
Most used30 mcg/kg nightly (children)
Highest60 mcg/kg per day (children). Adults: 2 mg nightly.

How it was given: Under the skin (SC)

Most trials were in children with low growth hormone. Adult studies were small.

Every study used for this page

Proof grade: Small human studies. Only small or uncontrolled human studies. Amounts are quoted as each study reported them. Where the abstract does not state an amount, the row says so.

StudyWho was studiedAmount given, as reportedRouteHow oftenHow longWhat the authors reported
PMID 83298251993Human, healthy men 19-43 yr (n = 30)IV: 0.25 mcg/kg (lowest tested), 1-2 mcg/kg (maximal GH release). Intranasal: dose-dependent, maximum response at about 50 mcg/kgIV or intranasalSingle doses. Repeated intranasal three times in one dayAcuteLowest IV dose gave significant GH release. Intranasal bioavailability only 3-5%
PMID 13792561992Human, healthy old men, 68 yr (n = 10)0.5 mg (low) and 1 mg (high) per injectionSCTwice daily14 days per dose, 14-day washout betweenHigh dose raised 24-h GH and IGF-I to young-man levels. Low dose did not reach significance
PMID 90059761997Human, healthy elderly men 64-76 yr (n = 11)2 mg GHRH (as reported "nightly subcutaneous self-injections of 2 mg GHRH")SCNightly, single injection6 weeksRaised nocturnal GH release. No change in IGF-I. Small muscle strength gains
PMID 87725991996Human, prepubertal GH-deficient children (110 treated, 86 analysed)30 mcgrams/kg per daySCOnce daily at bedtimeUp to 1 yearHeight velocity 4.1 to 8.0 cm/yr at 6 mo and 7.2 cm/yr at 12 mo. 74% good responders at 6 mo. Open label, no control
PMID 77353671994Human, prepubertal GH-deficient children (n = 16)30 mcgrams/kg, one daily doseSCOnce daily12 to 24 months11 of 16 responders, height velocity 3.4 to 6.5-6.8 cm/yr. Antibodies in some, no effect on growth
PMID 83298301993Human, GH-deficient children, hypothalamic origin (n = 60, 20 per group)30 or 60 mcgrams/kg/day (vs GH 0.1 IU/kg/day)Abstract says "continuous infusion" in its closing line, route otherwise not statedDaily6 monthsHeight velocity 9.2 and 9.3 cm/yr for 30 and 60 vs 14.6 with GH. No gain from the higher dose. Antibodies in 39 of 40
PMID 79554601994Human, children with idiopathic short stature (n = 18, 17 analysed)20 mcgrams/kg (iv test dose 1 mcgram/kg)SCTwice daily12 monthsHeight velocity 4.8 to 7.2 cm/yr. Fasting glucose and insulin rose
PMID 83298281993Human, GH-deficient children (n = 8)50 mcgrams/kg (IV stimulation test 1 mcgram/kg)IntranasalThree times per day6 monthsAbsorption and effect fell with time, antibodies in 3 of 8. Not suitable in that form

How to read the study numbers

  • One study, one group. Each figure is what one team chose for its own participants or animals.
  • Route matters. An amount given into a vein (IV) is not the same as the same amount under the skin, in the nose or by mouth.
  • Animals are not small people. An animal amount is shown as the study gave it. It is not a human amount.
  • Short studies. Many studies ran days or weeks. They do not show what happens over longer use.

Common questions

What amounts of Sermorelin were used in human studies?

In the studies listed here, people were given from 0.25 mcg/kg IV (test dose) up to 60 mcg/kg per day (children). Adults: 2 mg nightly.. The amount used most often was 30 mcg/kg nightly (children). These are what study teams chose for their participants under supervision.

Where do these Sermorelin numbers come from?

From 8 published studies, each linked to its PubMed or ClinicalTrials.gov record. Every figure was checked against the study abstract or its open full text. Proof grade: Small human studies.

How long does Sermorelin stay in the body?

Its half-life is about 6 to 7 minutes in the vein in people. Half-life is how long it takes for half of a dose to leave the blood. The effect can last longer than that.

Is this a recommendation for how much Sermorelin to use?

No. This page shows the amounts reported by drug labels, clinics and users, next to what researchers gave in studies. It is not medical advice and not a recommendation for anyone. Talk to a licensed clinician before using any of it.

See all peptides